FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Carbidopa and Levodopa Extended Release Tablets
Status: Currently in Shortage
»Date first posted: 09/27/2017
»Therapeutic Categories: Neurology

Expand all

Accord Healthcare Inc. (Revised 05/21/2018)

Company Contact Information:
866-941-7875, Option 1 or 3

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 1000CT; (NDC 1672907917) Product not available currently API procurement delay
CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 100CT; (NDC 1672907801) Unavailable Estimated recovery: December 2018 Manufacturing delay
CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 1000CT; (NDC 1672907817) Unavailable Estimated recovery: December 2018 Manufacturing delay
CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 100CT; (NDC 1672907901) Partial stock coverage available. Estimated recovery: August 2018 API procurement delay

Merck Sharp & Dohme Corp. (Revised 02/20/2018)

Company Contact Information:
800-637-2579

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
SINEMET CR 50-200 (carbidopa levodopa) Sustained-Release Tablets bottles of 100 (NDC 0006-3919-68) Product is available For additional information, please contact: Merck National Service Center at 1-800-672-6372 Demand increase for drug
SINEMET CR 25-100 (carbidopa levodopa) Sustained-Release Tablets bottles of 100 (NDC 0006-3918-68) Product currently available For additional information, please contact: Merck National Service Center at 1-800-672-6372 Demand increase for drug

Mylan Pharmaceuticals Inc. (Reverified 10/09/2018)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Carbidopa and Levodopa Extended Release Tablets, 25/100 mg (NDC 0378-0088-01) Available Other
Carbidopa and Levodopa Extended Release Tablets, 50/200 mg (NDC 0378-0094-01) Unavailable. Estimated recovery: October 2018. Other

Sun Pharmaceutical Industries Inc. (Revised 11/06/2017)

Company Contact Information:
800-810-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Carbidopa and Levodopa Extended Release Tablets 50-200 (NDC 62756-457-88) Available Sun has increased capacity to support additional demand. Demand increase for the drug
Carbidopa and Levodopa Extended Release Tablets 25-100 mg (NDC 62756-461-88 ) Unavailable Short-term backorder Demand increase of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English